DrugFeb 18, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle recall — FDA D-0306-2026
Tablets/Capsules Imprinted with Wrong ID
Class IIIFDA: OngoingUnichem Pharmaceuticals USA Inc.
Recall history in this database
Classification mix: Class III: 1, Class II: 1, Class I: 1.
DrugFeb 11, 2026
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle recall — FDA D-0301-2026
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Class IIFDA: OngoingUnichem Pharmaceuticals USA Inc.
DrugSep 24, 2025
Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle recall — FDA D-0655-2025
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in…
Class IFDA: OngoingUnichem Pharmaceuticals USA Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Unichem Pharmaceuticals USA Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.